Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4279 per EA under NDC 42858070703. Its NADAC has been published 398 times since Nov 14, 2018.
Strength
37.5 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858070703
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209293On Market Since
9/14/2018
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 398 times since Nov 14, 2018, and over the history we have for it it has declined 81.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4279 per EA |
|---|---|
| All-time high | $2.4367 (Mar 11, 2020) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $0.9265 |
| Average price | $1.1246 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 398 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PAROXETINE HYDROCHLORIDE HEMIHYDRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.4279 per EA (NDC 42858070703), effective Jun 24, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 81.2%. It has been tracked across 398 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Nov 14, 2018, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $2.4367 (Mar 11, 2020), with a median of $0.9265 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE ER 37.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 42858070703) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification